Stay updated with breaking news from Max Jakobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
University of Cambridge spin-out DeepMirror, software developers for the discovery of novel therapeutic drugs, has launched an Early Access Programme after a successful closed beta programme during which chemists were invited to test the software over several months. Click to read more...
DeepMirror, a University of Cambridge spin-out, introduces its Early Access Programme for intuitive design software dedicated to discovering innovative therapeutic drugs. Click to read more...
Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery.